{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T07:14:49Z","timestamp":1781939689473,"version":"3.54.5"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-022-03282-7","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T02:02:31Z","timestamp":1671069751000},"page":"160-173","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Follow, consider, and catch: second primary tumors in acromegaly patients"],"prefix":"10.1007","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7781-944X","authenticated-orcid":false,"given":"Seda Hanife","family":"Oguz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9072-5683","authenticated-orcid":false,"given":"Busra","family":"Firlatan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6740-6708","authenticated-orcid":false,"given":"Suleyman Nahit","family":"Sendur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0513-1750","authenticated-orcid":false,"given":"Selcuk","family":"Dagdelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1377-9394","authenticated-orcid":false,"given":"Tomris","family":"Erbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,15]]},"reference":[{"issue":"1","key":"3282_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41572-019-0071-6","volume":"5","author":"A Colao","year":"2019","unstructured":"A. Colao, L.F.S. Grasso, A. Giustina et al. Acromegaly. Nat. Rev. Dis. Prim. 5(1), 20 (2019). https:\/\/doi.org\/10.1038\/s41572-019-0071-6.","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"4","key":"3282_CR2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11102-013-0501-5","volume":"17","author":"S Dagdelen","year":"2014","unstructured":"S. Dagdelen, N. Cinar, T. Erbas, Increased thyroid cancer risk in acromegaly. Pituitary 17(4), 299\u2013306 (2014). https:\/\/doi.org\/10.1007\/s11102-013-0501-5.","journal-title":"Pituitary"},{"issue":"10","key":"3282_CR3","doi-asserted-by":"publisher","first-page":"3894","DOI":"10.1210\/jc.2015-2372","volume":"100","author":"D Petroff","year":"2015","unstructured":"D. Petroff, A. Tonjes, M. Grussendorf et al. The Incidence of Cancer Among Acromegaly Patients: Results From the German Acromegaly Registry. J. Clin. Endocrinol. Metab. 100(10), 3894\u20133902 (2015). https:\/\/doi.org\/10.1210\/jc.2015-2372.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"3282_CR4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1530\/ERC-16-0553","volume":"24","author":"M Terzolo","year":"2017","unstructured":"M. Terzolo, G. Reimondo, P. Berchialla et al. Acromegaly is associated with increased cancer risk: a survey in Italy. Endocr. Relat. Cancer. 24(9), 495\u2013504 (2017). https:\/\/doi.org\/10.1530\/ERC-16-0553.","journal-title":"Endocr. Relat. Cancer."},{"issue":"12","key":"3282_CR5","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1210\/clinem\/dgab560","volume":"106","author":"D Esposito","year":"2021","unstructured":"D. Esposito, O. Ragnarsson, G. Johannsson et al. Incidence of Benign and Malignant Tumors in Patients With Acromegaly Is Increased: A Nationwide Population-based Study. J. Clin. Endocrinol. Metab. 106(12), 3487\u20133496 (2021). https:\/\/doi.org\/10.1210\/clinem\/dgab560.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"3282_CR6","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s11102-021-01198-5","volume":"25","author":"M Fleseriu","year":"2022","unstructured":"M. Fleseriu, A. Barkan, M. Del Pilar Schneider et al. Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States. Pituitary 25(2), 296\u2013307 (2022). https:\/\/doi.org\/10.1007\/s11102-021-01198-5.","journal-title":"Pituitary"},{"issue":"4","key":"3282_CR7","doi-asserted-by":"publisher","first-page":"R147","DOI":"10.1530\/EJE-16-0178","volume":"175","author":"CL Boguszewski","year":"2016","unstructured":"C.L. Boguszewski, J. Ayuk, MANAGEMENT OF ENDOCRINE DISEASE: Acromegaly and cancer: an old debate revisited. Eur. J. Endocrinol. 175(4), R147\u2013R156 (2016). https:\/\/doi.org\/10.1530\/EJE-16-0178.","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"3282_CR8","doi-asserted-by":"publisher","first-page":"D1","DOI":"10.1530\/EJE-19-1009","volume":"183","author":"M Terzolo","year":"2020","unstructured":"M. Terzolo, S. Puglisi, G. Reimondo et al. Thyroid and colorectal cancer screening in acromegaly patients: should it be different from that in the general population? Eur. J. Endocrinol. 183(4), D1\u2013D13 (2020). https:\/\/doi.org\/10.1530\/EJE-19-1009.","journal-title":"Eur. J. Endocrinol."},{"issue":"11","key":"3282_CR9","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"L. Katznelson, E.R. Laws Jr., S. Melmed et al. Acromegaly: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99(11), 3933\u20133951 (2014). https:\/\/doi.org\/10.1210\/jc.2014-2700.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"3282_CR10","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1001\/jamaoncol.2017.3605","volume":"4","author":"CC Murphy","year":"2018","unstructured":"C.C. Murphy, D.E. Gerber, S.L. Pruitt, Prevalence of Prior Cancer Among Persons Newly Diagnosed With Cancer: An Initial Report From the Surveillance, Epidemiology, and End Results Program. JAMA Oncol. 4(6), 832\u2013836 (2018). https:\/\/doi.org\/10.1001\/jamaoncol.2017.3605.","journal-title":"JAMA Oncol."},{"issue":"24","key":"3282_CR11","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1001\/jama.2020.23130","volume":"324","author":"H Sung","year":"2020","unstructured":"H. Sung, N. Hyun, C.R. Leach et al. Association of First Primary Cancer With Risk of Subsequent Primary Cancer Among Survivors of Adult-Onset Cancers in the United States. JAMA 324(24), 2521\u20132535 (2020). https:\/\/doi.org\/10.1001\/jama.2020.23130.","journal-title":"JAMA"},{"key":"3282_CR12","unstructured":"Copur M.S., Manapuram S. Multiple Primary Tumors Over a Lifetime. Oncology (Williston Park). 2019;33(7)."},{"issue":"4","key":"3282_CR13","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1046\/j.1365-2265.1998.00536.x","volume":"49","author":"V Popovic","year":"1998","unstructured":"V. Popovic, S. Damjanovic, D. Micic et al. Increased incidence of neoplasia in patients with pituitary adenomas. The Pituitary Study Group. Clin. Endocrinol. (Oxf.) 49(4), 441\u2013445 (1998). https:\/\/doi.org\/10.1046\/j.1365-2265.1998.00536.x.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"5","key":"3282_CR14","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1530\/EJE-16-1064","volume":"176","author":"L Maione","year":"2017","unstructured":"L. Maione, T. Brue, A. Beckers et al. Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry. Eur. J. Endocrinol. 176(5), 645\u2013655 (2017). https:\/\/doi.org\/10.1530\/EJE-16-1064.","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"3282_CR15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s40618-016-0565-y","volume":"40","author":"K Wolinski","year":"2017","unstructured":"K. Wolinski, A. Stangierski, K. Dyrda et al. Risk of malignant neoplasms in acromegaly: a case-control study. J. Endocrinol. Invest. 40(3), 319\u2013322 (2017). https:\/\/doi.org\/10.1007\/s40618-016-0565-y.","journal-title":"J. Endocrinol. Invest."},{"issue":"1","key":"3282_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4158\/EP-2020-0398","volume":"27","author":"B Ucan","year":"2021","unstructured":"B. Ucan, M. Kizilgul, A.C. Karci et al. The Prevalence of Cancer and Its Relation to Disease Activity in Patients with Acromegaly: Two Centers\u2019 Experience. Endocr. Pract. 27(1), 51\u201355 (2021). https:\/\/doi.org\/10.4158\/EP-2020-0398.","journal-title":"Endocr. Pract."},{"issue":"1","key":"3282_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11102-012-0383-y","volume":"16","author":"MC dos Santos","year":"2013","unstructured":"M.C. dos Santos, G.C. Nascimento, A.G. Nascimento et al. Thyroid cancer in patients with acromegaly: a case-control study. Pituitary 16(1), 109\u2013114 (2013). https:\/\/doi.org\/10.1007\/s11102-012-0383-y.","journal-title":"Pituitary"},{"issue":"6","key":"3282_CR18","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1210\/jc.2017-02457","volume":"103","author":"J Dal","year":"2018","unstructured":"J. Dal, M.Z. Leisner, K. Hermansen et al. Cancer Incidence in Patients With Acromegaly: A Cohort Study and Meta-Analysis of the Literature. J. Clin. Endocrinol. Metab. 103(6), 2182\u20132188 (2018). https:\/\/doi.org\/10.1210\/jc.2017-02457.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"3282_CR19","doi-asserted-by":"publisher","first-page":"e110241","DOI":"10.1371\/journal.pone.0110241","volume":"9","author":"HK Kim","year":"2014","unstructured":"H.K. Kim, J.S. Lee, M.H. Park et al. Tumorigenesis of papillary thyroid cancer is not BRAF-dependent in patients with acromegaly. PLoS One. 9(10), e110241 (2014). https:\/\/doi.org\/10.1371\/journal.pone.0110241.","journal-title":"PLoS One."},{"issue":"3","key":"3282_CR20","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1055\/s-0035-1565061","volume":"124","author":"K Aydin","year":"2016","unstructured":"K. Aydin, C. Aydin, S. Dagdelen et al. Genetic Alterations in Differentiated Thyroid Cancer Patients with Acromegaly. Exp. Clin. Endocrinol. Diabetes. 124(3), 198\u2013202 (2016). https:\/\/doi.org\/10.1055\/s-0035-1565061.","journal-title":"Exp. Clin. Endocrinol. Diabetes."},{"issue":"7","key":"3282_CR21","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1055\/a-0629-9223","volume":"127","author":"FE Keskin","year":"2019","unstructured":"F.E. Keskin, H.M. Ozkaya, S. Ferahman et al. The Role of Different Molecular Markers in Papillary Thyroid Cancer Patients with Acromegaly. Exp. Clin. Endocrinol. Diabetes. 127(7), 437\u2013444 (2019). https:\/\/doi.org\/10.1055\/a-0629-9223.","journal-title":"Exp. Clin. Endocrinol. Diabetes."},{"issue":"1","key":"3282_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11102-018-0923-1","volume":"22","author":"SC Dogansen","year":"2019","unstructured":"S.C. Dogansen, A. Salmaslioglu, G.Y. Yalin et al. Evaluation of the natural course of thyroid nodules in patients with acromegaly. Pituitary 22(1), 29\u201336 (2019). https:\/\/doi.org\/10.1007\/s11102-018-0923-1.","journal-title":"Pituitary"},{"issue":"1","key":"3282_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"B.R. Haugen, E.K. Alexander, K.C. Bible et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26(1), 1\u2013133 (2016). https:\/\/doi.org\/10.1089\/thy.2015.0020.","journal-title":"Thyroid"},{"issue":"6","key":"3282_CR24","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S2213-8587(20)30115-7","volume":"8","author":"M Li","year":"2020","unstructured":"M. Li, L. Dal Maso, S. Vaccarella, Global trends in thyroid cancer incidence and the impact of overdiagnosis. Lancet Diabetes Endocrinol. 8(6), 468\u2013470 (2020). https:\/\/doi.org\/10.1016\/S2213-8587(20)30115-7.","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"5","key":"3282_CR25","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1136\/gut.2009.179804","volume":"59","author":"SR Cairns","year":"2010","unstructured":"S.R. Cairns, J.H. Scholefield, R.J. Steele et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 59(5), 666\u2013689 (2010). https:\/\/doi.org\/10.1136\/gut.2009.179804.","journal-title":"Gut"},{"issue":"4","key":"3282_CR26","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/s11102-014-0586-5","volume":"18","author":"K Lois","year":"2015","unstructured":"K. Lois, J. Bukowczan, P. Perros et al. The role of colonoscopic screening in acromegaly revisited: review of current literature and practice guidelines. Pituitary 18(4), 568\u2013574 (2015). https:\/\/doi.org\/10.1007\/s11102-014-0586-5.","journal-title":"Pituitary"},{"key":"3282_CR27","unstructured":"Republic of T\u00fcrkiye Ministery of Health, Department of Public Health, National Standards for Cancer Screening. https:\/\/hsgm.saglik.gov.tr\/tr\/kanser-tarama-standartlari\/listesi\/meme-kanseri-tarama-program%C4%B1-ulusal-standartlar%C4%B1.html."},{"key":"3282_CR28","unstructured":"In: nd, editor. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. WHO Guidelines Approved by the Guidelines Review Committee. Geneva2021."},{"issue":"9","key":"3282_CR29","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.annonc.2020.06.011","volume":"31","author":"C Parker","year":"2020","unstructured":"C. Parker, E. Castro, K. Fizazi et al. Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 31(9), 1119\u20131134 (2020). https:\/\/doi.org\/10.1016\/j.annonc.2020.06.011.","journal-title":"Ann. Oncol."},{"issue":"5","key":"3282_CR30","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1023\/a:1015713732717","volume":"13","author":"D Baris","year":"2002","unstructured":"D. Baris, G. Gridley, E. Ron et al. Acromegaly and cancer risk: a cohort study in Sweden and Denmark. Cancer Causes Control. 13(5), 395\u2013400 (2002). https:\/\/doi.org\/10.1023\/a:1015713732717.","journal-title":"Cancer Causes Control."},{"issue":"4","key":"3282_CR31","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1530\/eje.0.1510439","volume":"151","author":"A Mestron","year":"2004","unstructured":"A. Mestron, S.M. Webb, R. Astorga et al. Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA). Eur. J. Endocrinol. 151(4), 439\u2013446 (2004). https:\/\/doi.org\/10.1530\/eje.0.1510439.","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"3282_CR32","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.1365-2265.2009.03619.x","volume":"72","author":"R Kauppinen-Makelin","year":"2010","unstructured":"R. Kauppinen-Makelin, T. Sane, M.J. Valimaki et al. Increased cancer incidence in acromegaly\u2013a nationwide survey. Clin. Endocrinol. (Oxf.). 72(2), 278\u2013279 (2010). https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03619.x.","journal-title":"Clin. Endocrinol. (Oxf.)."},{"issue":"11-12","key":"3282_CR33","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1159\/000505332","volume":"110","author":"JC Wu","year":"2020","unstructured":"J.C. Wu, W.C. Huang, H.K. Chang et al. Natural History of Acromegaly: Incidences, Re-operations, Cancers, and Mortality Rates in a National Cohort. Neuroendocrinology 110(11-12), 977\u2013987 (2020). https:\/\/doi.org\/10.1159\/000505332.","journal-title":"Neuroendocrinology"},{"issue":"8","key":"3282_CR34","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1210\/jcem.83.8.5007","volume":"83","author":"SM Orme","year":"1998","unstructured":"S.M. Orme, R.J. McNally, R.A. Cartwright et al. Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J. Clin. Endocrinol. Metab. 83(8), 2730\u20132734 (1998). https:\/\/doi.org\/10.1210\/jcem.83.8.5007.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3282_CR35","unstructured":"Global Cancer Statistics 2020 (GLOBOCAN) Fact Sheets. https:\/\/gco.iarc.fr\/today\/data\/factsheets\/populations\/792-turkey-fact-sheets.pdf 2020."},{"issue":"6","key":"3282_CR36","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/modpathol.2017.9","volume":"30","author":"U Cho","year":"2017","unstructured":"U. Cho, O. Mete, M.H. Kim et al. Molecular correlates and rate of lymph node metastasis of non-invasive follicular thyroid neoplasm with papillary-like nuclear features and invasive follicular variant papillary thyroid carcinoma: the impact of rigid criteria to distinguish non-invasive follicular thyroid neoplasm with papillary-like nuclear features. Mod. Pathol. 30(6), 810\u2013825 (2017). https:\/\/doi.org\/10.1038\/modpathol.2017.9.","journal-title":"Mod. Pathol."},{"issue":"4","key":"3282_CR37","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/MPA.0b013e31823d7b36","volume":"41","author":"RP Jury","year":"2012","unstructured":"R.P. Jury, B.J. Thibodeau, L.E. Fortier et al. Gene expression changes associated with the progression of intraductal papillary mucinous neoplasms. Pancreas 41(4), 611\u2013618 (2012). https:\/\/doi.org\/10.1097\/MPA.0b013e31823d7b36.","journal-title":"Pancreas"},{"issue":"1","key":"3282_CR38","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1002\/lary.28052","volume":"130","author":"A Shay","year":"2020","unstructured":"A. Shay, A. Ganti, A. Raman et al. Survival in low-grade and high-grade sinonasal adenocarcinoma: A national cancer database analysis. Laryngoscope 130(1), E1\u2013E10 (2020). https:\/\/doi.org\/10.1002\/lary.28052.","journal-title":"Laryngoscope"},{"issue":"1","key":"3282_CR39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1442-2042.2006.01665.x","volume":"14","author":"HK Park","year":"2007","unstructured":"H.K. Park, S. Zhang, M.K. Wong et al. Clinical presentation of epithelioid angiomyolipoma. Int J. Urol. 14(1), 21\u201325 (2007). https:\/\/doi.org\/10.1111\/j.1442-2042.2006.01665.x.","journal-title":"Int J. Urol."},{"key":"3282_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-83","volume":"11","author":"DR Youlden","year":"2011","unstructured":"D.R. Youlden, P.D. Baade, The relative risk of second primary cancers in Queensland, Australia: a retrospective cohort study. BMC Cancer. 11, 83 (2011). https:\/\/doi.org\/10.1186\/1471-2407-11-83.","journal-title":"BMC Cancer."},{"issue":"1","key":"3282_CR41","doi-asserted-by":"publisher","first-page":"E57","DOI":"10.1503\/cmaj.110167","volume":"184","author":"SF Nielsen","year":"2012","unstructured":"S.F. Nielsen, B.G. Nordestgaard, S.E. Bojesen, Associations between first and second primary cancers: a population-based study. CMAJ 184(1), E57\u2013E69 (2012). https:\/\/doi.org\/10.1503\/cmaj.110167.","journal-title":"CMAJ"},{"issue":"1","key":"3282_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6452-0","volume":"20","author":"A Feller","year":"2020","unstructured":"A. Feller, K.L. Matthes, A. Bordoni et al. The relative risk of second primary cancers in Switzerland: a population-based retrospective cohort study. BMC Cancer. 20(1), 51 (2020). https:\/\/doi.org\/10.1186\/s12885-019-6452-0.","journal-title":"BMC Cancer."},{"issue":"3","key":"3282_CR43","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s11764-013-0278-6","volume":"7","author":"M Corkum","year":"2013","unstructured":"M. Corkum, J.A. Hayden, G. Kephart et al. Screening for new primary cancers in cancer survivors compared to non-cancer controls: a systematic review and meta-analysis. J. Cancer Surviv. 7(3), 455\u2013463 (2013). https:\/\/doi.org\/10.1007\/s11764-013-0278-6.","journal-title":"J. Cancer Surviv."},{"issue":"1","key":"3282_CR44","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10549-015-3456-6","volume":"152","author":"KR Joseph","year":"2015","unstructured":"K.R. Joseph, S. Edirimanne, G.D. Eslick, The association between breast cancer and thyroid cancer: a meta-analysis. Breast Cancer Res Treat. 152(1), 173\u2013181 (2015). https:\/\/doi.org\/10.1007\/s10549-015-3456-6.","journal-title":"Breast Cancer Res Treat."},{"issue":"4","key":"3282_CR45","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1245\/s10434-012-2718-3","volume":"20","author":"VL Van Fossen","year":"2013","unstructured":"V.L. Van Fossen, S.M. Wilhelm, J.L. Eaton et al. Association of thyroid, breast and renal cell cancer: a population-based study of the prevalence of second malignancies. Ann. Surg. Oncol. 20(4), 1341\u20131347 (2013). https:\/\/doi.org\/10.1245\/s10434-012-2718-3.","journal-title":"Ann. Surg. Oncol."},{"issue":"6","key":"3282_CR46","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1245\/s10434-011-2193-2","volume":"19","author":"G Lal","year":"2012","unstructured":"G. Lal, M. Groff, J.R. Howe et al. Risk of subsequent primary thyroid cancer after another malignancy: latency trends in a population-based study. Ann. Surg. Oncol. 19(6), 1887\u20131896 (2012). https:\/\/doi.org\/10.1245\/s10434-011-2193-2.","journal-title":"Ann. Surg. Oncol."},{"issue":"2","key":"3282_CR47","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/hed.24937","volume":"40","author":"K Hirvonen","year":"2018","unstructured":"K. Hirvonen, M. Rantanen, A. Haapaniemi et al. Second primary cancer after major salivary gland carcinoma. Head. Neck 40(2), 251\u2013258 (2018). https:\/\/doi.org\/10.1002\/hed.24937.","journal-title":"Head. Neck"},{"issue":"1","key":"3282_CR48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0030-4220(84)90367-0","volume":"58","author":"MA Pogrel","year":"1984","unstructured":"M.A. Pogrel, L.S. Hansen, Second primary tumor associated with salivary gland cancer. Oral. Surg. Oral. Med Oral. Pathol. 58(1), 71\u201375 (1984). https:\/\/doi.org\/10.1016\/0030-4220(84)90367-0.","journal-title":"Oral. Surg. Oral. Med Oral. Pathol."},{"issue":"2","key":"3282_CR49","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1210\/jc.2007-1154","volume":"93","author":"AP Brown","year":"2008","unstructured":"A.P. Brown, J. Chen, Y.J. Hitchcock et al. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. J. Clin. Endocrinol. Metab. 93(2), 504\u2013515 (2008). https:\/\/doi.org\/10.1210\/jc.2007-1154.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3282_CR50","doi-asserted-by":"publisher","unstructured":"M. Kim, H. Kim, S. Park, et al. Risk factors for second primary malignancies following thyroid cancer: a nationwide cohort study. Eur J Endocrinol. 2022. https:\/\/doi.org\/10.1530\/EJE-21-1208.","DOI":"10.1530\/EJE-21-1208"},{"issue":"9","key":"3282_CR51","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1038\/sj.bjc.6601319","volume":"89","author":"C Rubino","year":"2003","unstructured":"C. Rubino, F. de Vathaire, M.E. Dottorini et al. Second primary malignancies in thyroid cancer patients. Br. J. Cancer 89(9), 1638\u20131644 (2003). https:\/\/doi.org\/10.1038\/sj.bjc.6601319.","journal-title":"Br. J. Cancer"},{"issue":"5","key":"3282_CR52","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1089\/thy.2011.0406","volume":"23","author":"C Kim","year":"2013","unstructured":"C. Kim, X. Bi, D. Pan et al. The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomas. Thyroid 23(5), 575\u2013582 (2013). https:\/\/doi.org\/10.1089\/thy.2011.0406.","journal-title":"Thyroid"},{"issue":"8","key":"3282_CR53","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1089\/thy.2016.0655","volume":"27","author":"M Silva-Vieira","year":"2017","unstructured":"M. Silva-Vieira, S. Carrilho Vaz, S. Esteves et al. Second Primary Cancer in Patients with Differentiated Thyroid Cancer: Does Radioiodine Play a Role? Thyroid 27(8), 1068\u20131076 (2017). https:\/\/doi.org\/10.1089\/thy.2016.0655.","journal-title":"Thyroid"},{"issue":"10","key":"3282_CR54","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1002\/ijc.33116","volume":"147","author":"V Cappagli","year":"2020","unstructured":"V. Cappagli, A. Caldarella, G. Manneschi et al. Nonthyroidal second primary malignancies in differentiated thyroid cancer patients: Is the incidence increased comparing to the general population and could it be a radioiodine therapy consequence? Int J. Cancer 147(10), 2838\u20132846 (2020). https:\/\/doi.org\/10.1002\/ijc.33116.","journal-title":"Int J. Cancer"},{"issue":"4","key":"3282_CR55","doi-asserted-by":"publisher","first-page":"e88","DOI":"10.1097\/IOP.0000000000000798","volume":"33","author":"PJ Cimino","year":"2017","unstructured":"P.J. Cimino, Y.V. Sychev, L.F. Gonzalez-Cuyar et al. Primary Gliosarcoma of the Optic Nerve: A Unique Adult Optic Pathway Glioma. Ophthalmic Plast. Reconstr. Surg. 33(4), e88\u2013e92 (2017). https:\/\/doi.org\/10.1097\/IOP.0000000000000798.","journal-title":"Ophthalmic Plast. Reconstr. Surg."},{"issue":"7","key":"3282_CR56","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.radcr.2021.04.001","volume":"16","author":"RMA Prado","year":"2021","unstructured":"R.M.A. Prado, B.P. Tamura, G.D. Gomez, Optic pathway gliosarcoma: A very rare location for a rare disease. Radio. Case Rep. 16(7), 1665\u20131668 (2021). https:\/\/doi.org\/10.1016\/j.radcr.2021.04.001.","journal-title":"Radio. Case Rep."},{"key":"3282_CR57","doi-asserted-by":"publisher","unstructured":"R. Tuna, B. Carvalho, L. Castro, et al. Primary gliosarcoma of the optic nerve \u2013 Case report. Interdisciplinary Neurosurgery. 2020;20. https:\/\/doi.org\/10.1016\/j.inat.2020.100688.","DOI":"10.1016\/j.inat.2020.100688"},{"issue":"1","key":"3282_CR58","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3171\/2009.3.JNS081081","volume":"112","author":"SJ Han","year":"2010","unstructured":"S.J. Han, I. Yang, T. Tihan et al. Secondary gliosarcoma: a review of clinical features and pathological diagnosis. J. Neurosurg. 112(1), 26\u201332 (2010). https:\/\/doi.org\/10.3171\/2009.3.JNS081081.","journal-title":"J. Neurosurg."},{"issue":"7","key":"3282_CR59","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/oxfordjournals.annonc.a058944","volume":"5","author":"M Domenech-Santasusana","year":"1994","unstructured":"M. Domenech-Santasusana, J. Carles, A. Goday et al. Association of acromegaly and two malignancies: colorectal cancer and non-Hodgkin\u2019s lymphoma. Ann. Oncol. 5(7), 659 (1994). https:\/\/doi.org\/10.1093\/oxfordjournals.annonc.a058944.","journal-title":"Ann. Oncol."},{"issue":"1","key":"3282_CR60","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s12032-008-9084-9","volume":"26","author":"A Taslipinar","year":"2009","unstructured":"A. Taslipinar, E. Bolu, L. Kebapcilar et al. Insulin-like growth factor-1 is essential to the increased mortality caused by excess growth hormone: a case of thyroid cancer and non-Hodgkin\u2019s lymphoma in a patient with pituitary acromegaly. Med Oncol. 26(1), 62\u201366 (2009). https:\/\/doi.org\/10.1007\/s12032-008-9084-9.","journal-title":"Med Oncol."},{"issue":"15","key":"3282_CR61","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.2169\/internalmedicine.48.1916","volume":"48","author":"N Sekizawa","year":"2009","unstructured":"N. Sekizawa, E. Hayakawa, K. Tsuchiya et al. Acromegaly associated with multiple tumors. Intern Med. 48(15), 1273\u20131278 (2009). https:\/\/doi.org\/10.2169\/internalmedicine.48.1916.","journal-title":"Intern Med."},{"issue":"9","key":"3282_CR62","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1507\/endocrj.ej11-0324","volume":"59","author":"K Kato","year":"2012","unstructured":"K. Kato, Y. Takeshita, H. Misu et al. Duodenal adenocarcinoma with neuroendocrine features in a patient with acromegaly and thyroid papillary adenocarcinoma: a unique combination of endocrine neoplasia. Endocr. J. 59(9), 791\u2013796 (2012). https:\/\/doi.org\/10.1507\/endocrj.ej11-0324.","journal-title":"Endocr. J."},{"issue":"8","key":"3282_CR63","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1590\/s0004-27302012000800008","volume":"56","author":"CL Boguszewski","year":"2012","unstructured":"C.L. Boguszewski, T.M. Fighera, A. Bornschein et al. Genetic studies in a coexistence of acromegaly, pheochromocytoma, gastrointestinal stromal tumor (GIST) and thyroid follicular adenoma. Arq. Bras. Endocrinol. Metab. 56(8), 507\u2013512 (2012). https:\/\/doi.org\/10.1590\/s0004-27302012000800008.","journal-title":"Arq. Bras. Endocrinol. Metab."},{"key":"3282_CR64","doi-asserted-by":"publisher","unstructured":"Fountas A., Chai S.T., Ayuk J., et al. A rare challenging case of co-existent craniopharyngioma, acromegaly and squamous cell lung cancer. Endocr. Diab. Metab Case Rep. 2018;2018. https:\/\/doi.org\/10.1530\/EDM-18-0018.","DOI":"10.1530\/EDM-18-0018"},{"issue":"2","key":"3282_CR65","doi-asserted-by":"publisher","first-page":"213","DOI":"10.5603\/EP.a2019.0005","volume":"70","author":"A Jawiarczyk-Przybylowska","year":"2019","unstructured":"A. Jawiarczyk-Przybylowska, B. Wojtczak, J. Whitworth et al. Acromegaly associated with GIST, non-small cell lung carcinoma, clear cell renal carcinoma, multiple myeloma, medulla oblongata tumour, adrenal adenoma, and follicular thyroid nodules. Endokrynol. Pol. 70(2), 213\u2013217 (2019). https:\/\/doi.org\/10.5603\/EP.a2019.0005.","journal-title":"Endokrynol. Pol."},{"issue":"6","key":"3282_CR66","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/nrendo.2013.67","volume":"9","author":"RK Junnila","year":"2013","unstructured":"R.K. Junnila, E.O. List, D.E. Berryman et al. The GH\/IGF-1 axis in ageing and longevity. Nat. Rev. Endocrinol. 9(6), 366\u2013376 (2013). https:\/\/doi.org\/10.1038\/nrendo.2013.67.","journal-title":"Nat. Rev. Endocrinol."},{"issue":"4","key":"3282_CR67","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1530\/EJE-10-0859","volume":"164","author":"R Steuerman","year":"2011","unstructured":"R. Steuerman, O. Shevah, Z. Laron, Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies. Eur. J. Endocrinol. 164(4), 485\u2013489 (2011). https:\/\/doi.org\/10.1530\/EJE-10-0859.","journal-title":"Eur. J. Endocrinol."},{"issue":"10","key":"3282_CR68","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1210\/jc.2017-01000","volume":"102","author":"AL Brittain","year":"2017","unstructured":"A.L. Brittain, R. Basu, Y. Qian et al. Growth Hormone and the Epithelial-to-Mesenchymal Transition. J. Clin. Endocrinol. Metab. 102(10), 3662\u20133673 (2017). https:\/\/doi.org\/10.1210\/jc.2017-01000.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"3282_CR69","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrendo.2010.171","volume":"7","author":"PE Clayton","year":"2011","unstructured":"P.E. Clayton, I. Banerjee, P.G. Murray et al. Growth hormone, the insulin-like growth factor axis, insulin and cancer risk. Nat. Rev. Endocrinol. 7(1), 11\u201324 (2011). https:\/\/doi.org\/10.1038\/nrendo.2010.171.","journal-title":"Nat. Rev. Endocrinol."},{"issue":"4-5","key":"3282_CR70","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.cytogfr.2005.01.010","volume":"16","author":"S Yakar","year":"2005","unstructured":"S. Yakar, D. Leroith, P. Brodt, The role of the growth hormone\/insulin-like growth factor axis in tumor growth and progression: Lessons from animal models. Cytokine Growth Factor Rev. 16(4-5), 407\u2013420 (2005). https:\/\/doi.org\/10.1016\/j.cytogfr.2005.01.010.","journal-title":"Cytokine Growth Factor Rev."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03282-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-022-03282-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03282-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T11:35:22Z","timestamp":1680089722000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-022-03282-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["3282"],"URL":"https:\/\/doi.org\/10.1007\/s12020-022-03282-7","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,15]]},"assertion":[{"value":"1 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Hacettepe University (Date: 19.03.2019\/No: GO 19\/303).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}